1. Home
  2. GBX vs ORIC Comparison

GBX vs ORIC Comparison

Compare GBX & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

HOLD

Current Price

$46.33

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$11.05

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBX
ORIC
Founded
1974
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GBX
ORIC
Price
$46.33
$11.05
Analyst Decision
Sell
Strong Buy
Analyst Count
3
11
Target Price
$50.67
$18.78
AVG Volume (30 Days)
262.7K
1.2M
Earning Date
01-07-2026
11-13-2025
Dividend Yield
2.77%
N/A
EPS Growth
27.96
N/A
EPS
6.35
N/A
Revenue
$3,240,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.77
$3.90
52 Week High
$71.06
$14.93

Technical Indicators

Market Signals
Indicator
GBX
ORIC
Relative Strength Index (RSI) 64.61 40.42
Support Level $44.36 $10.45
Resistance Level $47.35 $12.14
Average True Range (ATR) 1.07 0.77
MACD 0.47 -0.08
Stochastic Oscillator 79.77 26.05

Price Performance

Historical Comparison
GBX
ORIC

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: